A positive Alzheimer’s blood biomarker test might mean that someone with cognitive impairment has beta-amyloid plaques in their brain. While some blood tests are extremely accurate, they aren’t validated against post-mortem brain tissue like cerebrospinal fluid tests and amyloid PET scans, so some clinicians are still cautious about using them.